杜邦宣布在PFAS承诺上取得了实质性进展

在运营改进，研究授权和技术获得的主要里程碑

威尔明顿，德尔明州，德国，2020年6月11日 - 杜邦今天宣布，它已经达成了几项里程碑，以履行2019年8月与每氟氟烷基物质（PFAS）相关的承诺。这些行动推进了公司实现其目标的计划2030可持续发展目标让世界更安全，更健康，更可持续。

“我们很高兴在提供与PFAS化学品相关的承诺方面取得了这一进展，因为我们努力实现我们的可持续发展和环境管理的核心价值，”杜邦的首席技术和可持续发展官Alexa Dembek表示。“我们期待着在这些承诺继续进展情况以及我们更广泛的2030年可持续发展目标时分享进一步的更新。”

迄今为止，杜邦达到了以下里程碑：

• 截至2019年底，消除了我们的产品和流程中的长链PFA，包括最近综合运营的使用。
• 在我们的许多网站上消除了基于PFAS的消防泡沫的购买和存储，并在2021年底（合法允许的地方）来消除我们网站上的所有基于PFA的消防泡沫的轨道。
• 在具有历史性PFAS占地面积的杜邦网站进行持续的修复。
• 在未来3年内为国家科学基金会（NSF）提供600万美元的无限制研究资金，以资助创新的PFAS修复技术。NSF最近要求新的PFAS研究提案作为这一倡议的一部分。www.nsf.gov/pubs/2020/nsf20090/nsf20090.jsp.
• 提供有关如何使用DuPont和其他制造商树脂技术的技术指导文档的开源访问，用于PFAS修复。www.lufeng-fst.com/pfas/remediation-technology-sharing.html.
• 支持杜邦的专有产品管理软件到包括伯克利中心的绿色化学中心，超越良性，罗格斯和其他组织。为了使该软件广泛访问其他人寻求指导对其业务中的化学替代品评估的别人，我们打算在ACS 24发射化学意识工具包^TH.年度绿色化学与工程会议于6月15日 - 19,2020。
• 与之参与ERM.是一个认可的第三方专家和领先的EHS和可持续发展相关服务提供商，审查我们对当前物质的管理，并使关切的物质进一步改善我们的流程和协议。

有关我们行动和审查完整PFAS承诺的更多信息，请访问我们www.lufeng-fst.com/pfas.并在Twitter @dupont_news上关注我们。

关于杜邦

杜邦（纽约证券交易所：DD）是一种全球创新领导者，具有基于技术的材料，配料和解决方案，可帮助改变行业和日常生活。我们的员工采用多样化的科学和专业知识，以帮助客户推进其最佳创意，并在包括电子，运输，建筑，水，健康，食品和工人安全的主要市场中提供基本创新。更多信息可以找到www.lufeng-fst.com/。

关于前瞻性陈述的警告声明

该沟通在联邦证券法中的含义内包含“前瞻性陈述”，包括1933年的“证券法”第27A条，如修订，以及1934年证券交易所第21E条，如修订。在这方面，前瞻性陈述往往地满足预期的未来业务和财务绩效和财务状况，通常包含“期待”等词语“预期”，“打算”，“计划，”“求，”“求，”“请参阅，”“意志”，“\”，“目标，”和类似的表达和这些词的变化或否定。

2019年4月1日，本公司通过职业奖励的所有Dow Inc.（“Dow Distribution”的所有杰出股票完成了物料科学业务分为单独和独立的公共公司。）。本公司于2019年6月1日完成了其农业业务将其农业业务分解为一家独立的独立公共公司，以Pro RATA股息的所有股票股票在Corteva，Inc。（“Corteva Distribution”（“Corteva Distribution”））。

On December 15, 2019, DuPont and IFF announced they had entered definitive agreements to combine DuPont’s Nutrition & Biosciences business with IFF in a transaction that would result in IFF issuing shares to DuPont shareholders, pending customary closing conditions, other approvals including regulatory and that of IFF’s shareholders.

前瞻性的陈述地址的问题，不同程度地存在不确定性和一定的风险，不确定性和假设，其中许多是超出了杜邦公司的控制，这可能会导致实际结果与任何前瞻性声明中的表述存在重大差异。前瞻性陈述并不是未来业绩的保证。Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) the parties’ ability to meet expectations regarding the timing, completion and accounting and tax treatments of the proposed transaction with IFF; changes in relevant tax and other laws, (ii) failure to obtain necessary regulatory approvals, approval of IFF’s shareholders, anticipated tax treatment or any required financing or to satisfy any of the other conditions to the proposed transaction with IFF, (iii) the possibility that unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies that could impact the value, timing or pursuit of the proposed transaction with IFF, (iv) risks and costs and pursuit and/or implementation of the separation of the N&B Business, including timing anticipated to complete the separation, any changes to the configuration of businesses included in the separation if implemented, (v) risks and costs related to the Dow Distribution and the Corteva Distribution (together, the “Distributions”) including (a) with respect to achieving all expected benefits from the Distributions; (b) the incurrence of significant costs in connection with the Distributions, including costs to service debt incurred by the Company to establish the relative credit profiles of Corteva, Dow and DuPont and increased costs related to supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common control of DuPont; (c) indemnification of certain legacy liabilities of E. I. du Pont de Nemours and Company ("Historical EID") in connection with the Corteva Distribution; and (d) potential liability arising from fraudulent conveyance and similar laws in connection with the Distributions; (vi) failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes, including meeting conditions under the Letter Agreement entered in connection with the Corteva Distribution, related to the transfer of certain levels of assets and businesses; (vii) uncertainty as to the long-term value of DuPont common stock; (viii) potential inability or reduced access to the capital markets or increased cost of borrowings, including as a result of a credit rating downgrade (ix) risks and uncertainties related to the novel coronavirus (COVID-19) and the responses thereto (such as voluntary and in some cases, mandatory quarantines as well as shut downs and other restrictions on travel and commercial, social and other activities) on DuPont’s business, results of operations, access to sources of liquidity and financial condition which depend on highly uncertain and unpredictable future developments, including, but not limited to, the duration and spread of the COVID-19 outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions resume. and (x) other risks to DuPont's business, operations and results of operations including from: failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including tariffs, trade disputes and retaliatory actions; impairment of goodwill or intangible assets; the availability of and fluctuations in the cost of energy and raw materials; business or supply disruption, including in connection with the Distributions; ability to effectively manage costs as the company’s portfolio evolves; security threats, such as acts of sabotage, terrorism or war, global health concerns and pandemics, natural disasters and weather events and patterns which could or could continue to result in a significant operational event for DuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DuPont's intellectual property rights; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DuPont's current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission, in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” (Part I, Item 1A) of DuPont’s 2019 Annual Report on Form 10-K, Item 8.01 of DuPont’s current report on Form 8-K filed on April 20, 2020 and as updated by DuPont’s subsequent periodic and current reports filed with the SEC.

#########

6/11/20

Dupont™，Dupont椭圆徽标以及用™，℠或®表示的所有商标和服务标志由Dupont de Nemours，Inc。的附属公司拥有。除非另有说明，否则除非另有说明。

有关详细信息，请联系：

丹特纳

+1（302）299-7628

daniel.a.turner@dupont.com.